Wiktor Kuliczkowski
Overview
Explore the profile of Wiktor Kuliczkowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Antkiewicz M, Kuliczkowski W, Protasiewicz M, Zubilewicz T, Terlecki P, Kobielarz M, et al.
Int J Environ Res Public Health
. 2022 Nov;
19(21).
PMID: 36361444
Open thoracoabdominal repair is the gold standard in the TAAA treatment. However, there are endovascular techniques, that sometimes may be an alternative, such as branched endovascular aneurysm repair (BEVAR) or...
32.
Frydrychowski P, Michalek M, Kuliczkowski W, Nowak K, Skrzypczak P, Bil-Lula I, et al.
J Vet Res
. 2022 Nov;
66(3):435-447.
PMID: 36349138
Introduction: Acute myocardial infarction (MI) is one of the most common causes of death in humans in highly developed countries. Among its most frequent complications affecting the patient's prognosis are...
33.
Blaziak M, Urban S, Wietrzyk W, Jura M, Iwanek G, Stanczykiewicz B, et al.
Biomedicines
. 2022 Sep;
10(9).
PMID: 36140289
Heart failure (HF) is one of the leading causes of mortality and hospitalization worldwide. The accurate prediction of mortality and readmission risk provides crucial information for guiding decision making. Unfortunately,...
34.
Antkiewicz M, Protasiewicz M, Kuliczkowski W, Zubilewicz T, Terlecki P, Kobielarz M, et al.
Vasc Health Risk Manag
. 2022 Sep;
18:677-684.
PMID: 36071744
Purpose: Numerous cases of abdominal aortic aneurysm (AAA) enlargement, and even rupture, despite endovascular aneurysm repair (EVAR), have been documented. This has been linked to increased aneurysm sac pressure (ASP)....
35.
Serebruany V, Tanguay J, Kuliczkowski W, Heidel E, Kim M, Atar D
Am J Med
. 2022 Aug;
135(11):1342-1348.
PMID: 35977606
Background: Bleeding remains a complication during dual antiplatelet therapy (DAPT) for acute coronary syndrome (ACS). Some data suggest a link between bleeding and worsened vascular outcomes. However, this association is...
36.
Konieczny R, Zurawska-Plaksej E, Kaaz K, Czapor-Irzabek H, Bombala W, Mysiak A, et al.
Cardiology
. 2022 Aug;
147(4):443-452.
PMID: 35970148
Introduction: Trimethylamine N-oxide (TMAO) is an organic compound with a well-established involvement in the pathogenesis of cardiovascular disease (CVD). However, data on the links between TMAO levels and cardiovascular mortality...
37.
Konieczny R, Zurawska-Plaksej E, Kaaz K, Czapor-Irzabek H, Bombala W, Mysiak A, et al.
Adv Clin Exp Med
. 2022 Jun;
31(10):1121-1128.
PMID: 35699588
Background: Cardiovascular disease (CVD) is associated with intestinal barrier dysfunction and increased intestinal permeability. Increased intestinal permeability to gut microbial metabolites may accelerate the progression of CVD. Plasma citrulline levels...
38.
Kozera L, Kuliczkowski W, Gocek E
Arch Med Sci
. 2022 May;
18(3):617-623.
PMID: 35591838
Introduction: Population biobanks are essential for the development of public health screening and improvement of personalized medicine. Since 2012, Biobank of Łukasiewicz Research Network - PORT Polish Center for Technology...
39.
Kubica J, Adamski P, Ladny J, Kazmierczak J, Fabiszak T, Filipiak K, et al.
Cardiol J
. 2022 May;
29(4):540-552.
PMID: 35514089
No abstract available.
40.
Konieczny R, Kuliczkowski W
Adv Clin Exp Med
. 2022 Apr;
31(8):913-925.
PMID: 35438848
Although traditional cardiovascular risk factors are well established and understood, mortality and morbidity in patients with cardiovascular disease (CVD) remains high. Exploring new pathophysiological pathways enables a better understanding of...